MidAmerica Cancer Care and American Oncology Network Welcome Dr. Syed Karim

Rhea-AI Summary

MidAmerica Cancer Care (AONC) announced that Dr. Syed Karim, a board-certified medical oncologist and hematologist, has joined the physician team and is accepting new patients at the Belton location.

Dr. Karim brings more than 10 years of clinical experience in the Kansas City area and completed fellowships at George Washington University and Georgetown University Hospital. For more information visit maccsp.com and AONcology.com.

News Market Reaction – AONC

+2.78%

+2.78% Session close to close

In the Apr 30 session, AONC gained 2.78%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement continues American Oncology Network’s strategy of expanding community-based oncolo...

Analysis

This announcement continues American Oncology Network’s strategy of expanding community-based oncology capabilities by adding experienced physicians, here through Dr. Karim joining MidAmerica Cancer Care. Recent history shows multiple practice partnerships and clinician hires across states like Oklahoma, Indiana, and Arkansas, some linked to sizeable price moves up to 16.13% and down to -36.6%. Investors monitoring this story may focus on how additional hires translate into network scale and operational performance over time.

Key Figures

Share price: $9 Daily price change: 16.13% Today’s volume: 150 shares +5 more

8 metrics

Share price $9 Pre-news current price for AONC

Daily price change 16.13% Price change over the last 24 hours

Today’s volume 150 shares Trading volume on the day of the article

20-day avg volume 847 shares Average daily volume over prior 20 days

Market cap $17,045,635 Equity value before the news

Experience More than 10 years Dr. Karim’s practice in Kansas City area

Conference sessions 11 sessions AON participation at 2026 Community Oncology Alliance conference

Arkansas locations 11 locations Genesis Cancer and Blood Institute footprint

Historical Context

5 past events · Latest: Apr 22 (Positive)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Apr 22	Conference participation	Positive	+16.1%	AON leaders presenting 11 sessions at national oncology conference.
Mar 05	Practice partnership	Positive	-7.3%	Oncology Consultants joins AON, expanding South Texas footprint and resources.
Feb 04	Practice partnership	Positive	+4.3%	RKV Medical Center becomes AON’s first partner practice in Oklahoma.
Feb 03	Physician addition	Positive	+4.3%	Hematology Oncology of Indiana and AON welcome Dr. Amy Braden.
Jan 21	Staff additions	Positive	-36.6%	Genesis Cancer and Blood Institute adds endocrinologist and nurse practitioner.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

News on practice expansions and physician additions has produced mixed reactions, with some positive moves and at least one sharp selloff.

Recent Company History

Over recent months, American Oncology Network has repeatedly highlighted expansion of its community oncology footprint. Events include new partner practices in Oklahoma and South Texas, multiple physician additions in Indiana and Arkansas, and participation in 11 sessions at a major oncology conference. Price reactions have varied, from a 16.13% gain on conference participation to a -36.6% move following staff additions in Arkansas. Today’s MidAmerica Cancer Care physician hire fits this ongoing network-expansion narrative.

Key Terms

medical oncologist, hematologist, internal medicine, geriatric medicine, +4 more

8 terms

medical oncologist medical

"Dr. Karim is a Board-certified medical oncologist and hematologist..."

A medical oncologist is a doctor who diagnoses and treats cancer using medicines such as chemotherapy, targeted drugs and immunotherapy, and who coordinates overall medical care for cancer patients. Investors pay attention because these specialists decide which therapies patients receive and influence how quickly new drugs move from trials to routine use — like a coach whose playbook determines which new equipment actually gets used by the team.

hematologist medical

"Dr. Karim is a Board-certified medical oncologist and hematologist..."

A hematologist is a medical doctor who specializes in diagnosing and treating blood-related conditions, such as anemia, blood cancers, and clotting disorders. Their work is important because blood health can impact overall well-being and can influence the success of treatments for various diseases. For investors, understanding hematologists helps clarify advancements in medical research and therapies that may affect healthcare companies and markets.

internal medicine medical

"He then completed his internal medicine residency at the Henry Ford Health System..."

Internal medicine is the medical specialty that diagnoses and treats illnesses of the body’s internal systems in adults, such as heart, lung, kidney, digestive and metabolic conditions. Think of internists as general managers of adult health who decide which medicines, tests or specialists are needed; their decisions shape demand for drugs, diagnostics, hospital care and outpatient services, so shifts in internal medicine practice can affect healthcare company revenues and costs.

geriatric medicine medical

"before completing a geriatric medicine fellowship at George Washington University..."

Geriatric medicine is the branch of healthcare that focuses on diagnosing, treating and preventing health problems common in older adults, using approaches tailored to the physical, cognitive and social changes of aging. For investors it matters because an aging population shifts demand toward medicines, devices, services and long‑term care models designed for older patients, affecting market size, reimbursement, regulatory scrutiny and long-term revenue potential much like a specialized toolkit responding to a different kind of customer need.

hematology medical

"and a hematology and oncology fellowship at Georgetown University Hospital."

Hematology is the branch of medicine that studies blood, its components (like red and white cells and platelets), and disorders that affect them. For investors, it matters because treatments, diagnostics, and devices that diagnose or fix blood problems can drive sales, regulatory risk, and patent value—think of it as investments in the maintenance and repair of the body's delivery system, where breakthroughs or setbacks can quickly change a company's prospects.

oncology medical

"and a hematology and oncology fellowship at Georgetown University Hospital."

Oncology is the branch of medicine focused on understanding, diagnosing, and treating cancer, including the development and testing of drugs, therapies, and screening methods. It matters to investors because advances, trial results, regulatory approvals, or setbacks in cancer research can dramatically change the value of companies and the size of potential markets—think of oncology news as weather reports that help investors steer financial decisions in a high-stakes field.

clinical trials medical

"The partnership aims to expand access to clinical trials, advanced therapies..."

Clinical trials are carefully controlled studies that test whether a new drug, device or treatment is safe and effective in people, moving through successive stages that increase the number of participants and the rigor of testing. Investors care because trial outcomes determine whether a product can be approved and sold, shaping a company’s future revenue, valuation and risk profile—think of it as proof-of-concept testing that decides if a prototype becomes a market-ready product.

endocrinology medical

"The hires expand Genesis to offer onsite endocrinology alongside oncology..."

Endocrinology is the branch of medicine that studies hormones, which are chemicals produced by glands in the body that regulate important functions like growth, energy, and mood. Understanding how hormones work can reveal insights into health conditions and overall well-being. For investors, it highlights areas of medical research and pharmaceutical development that may influence healthcare trends and market opportunities.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

KANSAS CITY, Mo., April 30, 2026 (GLOBE NEWSWIRE) -- MidAmerica Cancer Care (MACC) and American Oncology Network (AON), one of the nation’s fastest-growing networks of community-based oncology practices, are pleased to announce that Syed Karim, MD, has joined the practice’s physician team and is now accepting new patients.

Dr. Karim is a Board-certified medical oncologist and hematologist who has been serving patients in the Kansas City area for more than 10 years. He earned his medical degree from Dow Medical College in Karachi, Pakistan. He then completed his internal medicine residency at the Henry Ford Health System, before completing a geriatric medicine fellowship at George Washington University and a hematology and oncology fellowship at Georgetown University Hospital.

“I’m pleased to join MidAmerica Cancer Care and collaborate with such a dedicated team,” said Dr. Karim. “The practice’s commitment to delivering high-quality, patient-centered care aligns closely with my own approach, and I look forward to working with them to support patients and their families throughout their treatment journey.”

“We are thrilled to welcome Dr. Karim to MidAmerica Cancer Care,” said Jaswinder Singh, MD. “His impressive background and commitment to evidence-based, compassionate care make him an excellent addition to our team and will further enhance the high standard of care we provide patients.”

MACC provides care to patients living in the Kansas City Metropolitan area, western Missouri and surrounding areas. The practice ensures patients receive personalized care and treatment plans that are designed to meet their unique needs. As a community-based practice, MACC offers affordable care in a comfortable environment while delivering high-quality, state-of-the-art treatment in convenient locations.

“On behalf of AON, I’m pleased to welcome Dr. Karim to MidAmerica Cancer Care and to our national network,” said Stephen “Fred” Divers, MD, AON’s chief medical officer. “His dedication to clinical excellence and patient-centered care reflects our mission and will strengthen the high-quality community oncology care we provide in the Kansas City area and throughout our network.”

Dr. Karim is now seeing patients at MidAmerica Cancer Care’s Belton location.

For more information about American Oncology Network, visit www.AONcology.com. For more information about MidAmerica Cancer Care, visit maccsp.com.

About MidAmerica Cancer Care
Established in 2019, MidAmerica Cancer Care (MACC) has one central mission: to provide compassionate cancer care to patients right in their own communities. Because tumors and cancers are unique, it is important to create a unique treatment plan for each patient. At MACC, treating the whole patient and not just the cancer itself, is an integral part of this approach. This is accomplished through leading-edge programs and technologies delivered in a highly personal and compassionate setting.

MidAmerica Cancer Care has six physicians and 16 advanced practitioners on staff, in three locations. With more than 50 years combined experience, MACC is dedicated to fighting for each patient as if they are family.

With its main location on the campus of St. Joseph Medical Center in Kansas City, MO, MACC visits with patients in multiple locations. Learn more at maccsp.com.

About American Oncology Network

American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 350 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com more information, or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/e3fc59c4-11b6-4f4c-a820-af61175b406f

Media Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com

FAQ

Who is Dr. Syed Karim and what is his role at MidAmerica Cancer Care (AONC)?

Dr. Syed Karim is a board-certified medical oncologist and hematologist joining MidAmerica Cancer Care. According to MidAmerica Cancer Care, he has over 10 years of clinical experience in the Kansas City area and completed hematology-oncology training at Georgetown University Hospital.

Is Dr. Syed Karim accepting new patients at MidAmerica Cancer Care Belton (AONC)?

Yes, Dr. Syed Karim is now accepting new patients at the Belton location. According to MidAmerica Cancer Care, he is seeing patients there and is available for clinical appointments and treatment planning for local oncology and hematology needs.

What are Dr. Syed Karim’s medical training and certifications listed by AONC?

Dr. Karim is board-certified in medical oncology and hematology with internal medicine residency and geriatric fellowship training. According to American Oncology Network, he completed residency at Henry Ford and fellowships at George Washington and Georgetown.

Which areas does MidAmerica Cancer Care serve and how does this hire affect local patients (AONC)?

MidAmerica Cancer Care serves the Kansas City metro, western Missouri, and nearby areas. According to MidAmerica Cancer Care, adding Dr. Karim expands physician capacity and supports continuity of community-based, patient-centered oncology services in those communities.

Where can patients find more information or schedule an appointment with Dr. Syed Karim at AONC?

Patients can find practice information and contact details on the clinic websites. According to MidAmerica Cancer Care, visit maccsp.com for scheduling and AONcology.com for network information and resources related to appointment options.